Your email has been successfully added to our mailing list.

×
0 0 0.00284495021337133 0.0021337126600284 -0.0014224751066856 -0.0142247510668563 -0.00995732574679947 -0.027027027027027
Stock impact report

Ad Com June 26 for Pain Therapeutics' Remoxy ER [Seeking Alpha]

PAIN THERAPEUTICS (PTIE) 
US:NASDAQ Investor Relations: investor.paintrials.com/investor-relations
Company Research Source: Seeking Alpha
Ad Com June 26 for Pain Therapeutics' Remoxy ERAn FDA advisory committee meeting istentatively scheduled for June 26 to discuss the Pain Therapeutics' (PTIE-1.5%) refiled marketing application seeking approval for paid med REMOXY ER (oxycodone extended-release CII).The company received a CRL in 2016 in response to its original submission citing the need for more clinical data.Previously:Pain Therapeutics refiles U.S. marketing application for Remoxy ER; shares up 3% (Feb. 13)Click to subscribe to real-time analytics on PTIENow read:Patent Losses Could Sink Allergan » Show less Read more
Impact Snapshot
Event Time:
PTIE
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
Last price at news event
Since Event
Multi-day stock performance from the time of the news release
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
LAST
PRICE AT
NEWS EVENT
SINCE EVENT
Multi-day stock performance from the time of the news release
Last Price
VWAP
High:
Max Up
High:
Low:
Max Down
Low:
%
Post news range
%
Price change

Price Change Percentage


S&P 500
(SPX)

%

Volume ratio
%

Volume
Ticks

Avg transaction size

Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Opt-in for PTIE alerts
Opt-in for
PTIE alerts

from News Quantified
Opt-in for
PTIE alerts

from News Quantified